Taiwan sits, along with its smaller counterparts, Singapore and Hong Kong, as one of the gateway countries to running a clinical trial in China. Although Hong Kong’s regulatory ties are more formalized with China, than Taiwan, Taiwan has the right environment and population to make the possibility of greater regulatory cohesion with its giant neighbour, […]
Read More
Clinical trial sponsors and CROs don’t need to imagine South Korea as a country of limitless potential, they know it is. South Korea is a clinical trial destination with world-class medical infrastructure, a highly-educated, relatively wealthy and healthy population. Their investigators are, on the whole, actively engaged in clinical trials and keen to play their […]
Read More
A recent article published in PharmAsia News highlighted the results of ground-breaking research, published in The New England Journal of Medicine (NEJM), that showed a lower dose of intravenous alteplase can reduce bleeds in the brain and improve survival rates in patients with acute ischemic stroke. While the results of ENCHANTED, a predominantly Asian study, […]
Read MoreGeorge Clinical (GC) is at the heart of developing Asia Clinical Research Professionals. This summer, our Clinical and Regulatory Manager, East Asia volunteered as a trainer for Asia Training Consortium (ATC) in its Foundational Clinical Project Management training program in Hong Kong. ATC is a non-profit organisation aimed at providing a unified platform for industry […]
Read More
